SK6892002A3 - Novel il-8 receptor antagonists - Google Patents

Novel il-8 receptor antagonists Download PDF

Info

Publication number
SK6892002A3
SK6892002A3 SK689-2002A SK6892002A SK6892002A3 SK 6892002 A3 SK6892002 A3 SK 6892002A3 SK 6892002 A SK6892002 A SK 6892002A SK 6892002 A3 SK6892002 A3 SK 6892002A3
Authority
SK
Slovakia
Prior art keywords
preparation
formula
indole
group
chloro
Prior art date
Application number
SK689-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Jean-Luc Paquet
Martine Barth
Didier Pruneau
Pierre Dodey
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Publication of SK6892002A3 publication Critical patent/SK6892002A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK689-2002A 1999-11-25 2000-11-24 Novel il-8 receptor antagonists SK6892002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9914837A FR2801585B1 (fr) 1999-11-25 1999-11-25 Nouveaux antagonistes des recepteurs de l'ii-8
PCT/FR2000/003278 WO2001038305A2 (fr) 1999-11-25 2000-11-24 Nouveaux antagonistes des recepteurs de l'il-8

Publications (1)

Publication Number Publication Date
SK6892002A3 true SK6892002A3 (en) 2002-10-08

Family

ID=9552533

Family Applications (1)

Application Number Title Priority Date Filing Date
SK689-2002A SK6892002A3 (en) 1999-11-25 2000-11-24 Novel il-8 receptor antagonists

Country Status (22)

Country Link
US (1) US6605633B1 (es)
EP (1) EP1232144B1 (es)
JP (1) JP2003514894A (es)
KR (1) KR20020050280A (es)
CN (1) CN1391556A (es)
AT (1) ATE263150T1 (es)
AU (1) AU2177601A (es)
BR (1) BR0015695A (es)
CA (1) CA2392225A1 (es)
CZ (1) CZ20021810A3 (es)
DE (1) DE60009544T2 (es)
ES (1) ES2218266T3 (es)
FR (1) FR2801585B1 (es)
HU (1) HUP0203603A3 (es)
IL (1) IL149838A0 (es)
MX (1) MXPA02005232A (es)
NO (1) NO20022460D0 (es)
NZ (1) NZ519126A (es)
PL (1) PL355724A1 (es)
RU (1) RU2002113771A (es)
SK (1) SK6892002A3 (es)
WO (1) WO2001038305A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824826B1 (fr) * 2001-05-17 2003-11-07 Fournier Lab Sa Nouveaux derives de 5-cyano-1h-indole antagonistes des recepteurs de l'interleukine-8
WO2003104180A1 (en) * 2002-06-05 2003-12-18 Natco Pharma Limited Process for the preparation of 4-(4-fluorobenzoyl) butyric acid
US7348338B2 (en) 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
NZ545326A (en) 2003-07-17 2009-12-24 Plexxikon Inc PPAR active compounds
JP2008521829A (ja) 2004-11-30 2008-06-26 プレキシコン,インコーポレーテッド Ppar活性化合物
PE20090159A1 (es) 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
SG11202105769XA (en) 2018-12-17 2021-07-29 Vertex Pharma Inhibitors of apol1 and methods of using same
CN116348447A (zh) 2020-01-29 2023-06-27 弗特克斯药品有限公司 Apol1的抑制剂及其使用其的方法
WO2021178768A1 (en) 2020-03-06 2021-09-10 Vertex Pharmaceuticals Incorporated Methods of treating apol-1 dependent focal segmental glomerulosclerosis
JP2023529216A (ja) * 2020-06-12 2023-07-07 バーテックス ファーマシューティカルズ インコーポレイテッド Apol1の阻害剤及びその使用
MX2023002269A (es) 2020-08-26 2023-05-16 Vertex Pharma Inhibidores de apol1 y metodos para usar los mismos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4514496A (en) * 1994-12-13 1996-07-03 Smithkline Beecham Corporation Novel compounds
AU8673198A (en) 1997-07-29 1999-02-22 Smithkline Beecham Corporation Il-8 receptor antagonists
GB9905010D0 (en) * 1999-03-04 1999-04-28 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
FR2801585A1 (fr) 2001-06-01
CZ20021810A3 (cs) 2002-08-14
HUP0203603A2 (hu) 2003-02-28
CN1391556A (zh) 2003-01-15
NZ519126A (en) 2006-03-31
PL355724A1 (en) 2004-05-17
EP1232144B1 (fr) 2004-03-31
DE60009544T2 (de) 2004-12-30
JP2003514894A (ja) 2003-04-22
ATE263150T1 (de) 2004-04-15
AU2177601A (en) 2001-06-04
MXPA02005232A (es) 2002-11-07
HUP0203603A3 (en) 2004-03-01
US6605633B1 (en) 2003-08-12
DE60009544D1 (de) 2004-05-06
FR2801585B1 (fr) 2002-02-15
NO20022460L (no) 2002-05-24
BR0015695A (pt) 2002-07-23
WO2001038305A2 (fr) 2001-05-31
RU2002113771A (ru) 2004-01-10
IL149838A0 (en) 2002-11-10
ES2218266T3 (es) 2004-11-16
KR20020050280A (ko) 2002-06-26
CA2392225A1 (en) 2001-05-31
EP1232144A2 (fr) 2002-08-21
WO2001038305A3 (fr) 2002-01-24
NO20022460D0 (no) 2002-05-24

Similar Documents

Publication Publication Date Title
JP5183628B2 (ja) Ep4受容体リガンドとしてのインドリンアミド誘導体
JP4397586B2 (ja) Ep4受容体に結合するナフタレン誘導体
JP5289046B2 (ja) Ep4アンタゴニストとしてのキノリン誘導体
JP4398150B2 (ja) ベンゾ(f)イソインドール誘導体およびそのEP4受容体リガンドとしての使用
JP2002536360A (ja) インドール誘導体およびそのmcp−1受容体拮抗剤としての使用
JPH06107637A (ja) ベンズアニリド誘導体
KR20080089416A (ko) 개폐 이온 통로를 조절하기 위한 조성물 및 방법
JPH05508845A (ja) 選択的ロイコトリエンb4拮抗活性を示す置換2環式ビス―アリール組成物、それらの調製および医薬組成物における使用
US20040138287A1 (en) Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
JP2009543835A (ja) インドール化合物
SK6892002A3 (en) Novel il-8 receptor antagonists
JP2558208B2 (ja) インダン誘導体及び該化合物を含有するトロンボキサン拮抗剤
JP2005539036A (ja) ピリミジン化合物
US20090163521A1 (en) Novel Pyrazolopyrimidinone Derivatives
US20050100902A1 (en) 5-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptors
JPH04502146A (ja) 医薬品として用いられるフェニルピロール化合物、その製造法及び用途
JPS61118386A (ja) トリアゾロキノリン誘導体
JPH09169729A (ja) 非ペプチド型インターロイキン8拮抗剤
JP2010501020A (ja) Ep4受容体アゴニストとしての新規イソインドール誘導体